Anika Therapeutics Announces Exclusive Latin America Distribution Agreement for ORTHOVISC Products with DePuy Mitek

BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (NASDAQ:ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid (HA) technology, announced today that it has signed an exclusive agreement with DePuy Mitek, Inc., a Johnson & Johnson company, to distribute and market ORTHOVISC® and ORTHOVISC® mini throughout Latin America. This five-year renewable agreement gives DePuy Mitek exclusive distribution rights for both products in all of South America, Central America, the Caribbean and Mexico. DePuy Mitek currently distributes ORTHOVISC in the United States.

MORE ON THIS TOPIC